These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 31974923)

  • 1. Advancing Mesenchymal Stem Cell Therapy with CRISPR/Cas9 for Clinical Trial Studies.
    Golchin A; Shams F; Karami F
    Adv Exp Med Biol; 2020; 1247():89-100. PubMed ID: 31974923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly efficient genome editing via CRISPR-Cas9 ribonucleoprotein (RNP) delivery in mesenchymal stem cells.
    Han AR; Shin HR; Kwon J; Lee SB; Lee SE; Kim EY; Kweon J; Chang EJ; Kim Y; Kim SW
    BMB Rep; 2024 Jan; 57(1):60-65. PubMed ID: 38053293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing the Therapeutic Potential of Mesenchymal Stem Cells with the CRISPR-Cas System.
    Filho DM; de Carvalho Ribeiro P; Oliveira LF; Dos Santos ALRT; Parreira RC; Pinto MCX; Resende RR
    Stem Cell Rev Rep; 2019 Aug; 15(4):463-473. PubMed ID: 31147819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges and advances in clinical applications of mesenchymal stromal cells.
    Zhou T; Yuan Z; Weng J; Pei D; Du X; He C; Lai P
    J Hematol Oncol; 2021 Feb; 14(1):24. PubMed ID: 33579329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal Stem Cell Engineering.
    Liu S
    Methods Mol Biol; 2018; 1868():145-150. PubMed ID: 30244462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid identification of genome-edited mesenchymal stem cell colonies via Cas9.
    Jiang W; Lian W; Chen J; Li W; Huang J; Lai B; Li L; Huang Z; Xu J
    Biotechniques; 2019 May; 66(5):231-234. PubMed ID: 30924368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-targeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: a path to clinical success?
    Gerace D; Martiniello-Wilks R; Nassif NT; Lal S; Steptoe R; Simpson AM
    Stem Cell Res Ther; 2017 Mar; 8(1):62. PubMed ID: 28279194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas9-engineered mesenchymal stromal/stem cells and their extracellular vesicles: A new approach to overcoming cell therapy limitations.
    Hazrati A; Malekpour K; Soudi S; Hashemi SM
    Biomed Pharmacother; 2022 Dec; 156():113943. PubMed ID: 36411629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular targeting regulation of proliferation and differentiation of the bone marrow-derived mesenchymal stem cells or mesenchymal stromal cells.
    Chen BY; Wang X; Chen LW; Luo ZJ
    Curr Drug Targets; 2012 Apr; 13(4):561-71. PubMed ID: 22443584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR technologies for stem cell engineering and regenerative medicine.
    Hsu MN; Chang YH; Truong VA; Lai PL; Nguyen TKN; Hu YC
    Biotechnol Adv; 2019 Dec; 37(8):107447. PubMed ID: 31513841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Editing and Human Pluripotent Stem Cells: Tools for Advancing Diabetes Disease Modeling and Beta-Cell Development.
    Millette K; Georgia S
    Curr Diab Rep; 2017 Oct; 17(11):116. PubMed ID: 28980194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances in Endocrine, Metabolic and Immune Disorders: Mesenchymal Stem Cells (MSCs) and Engineered Scaffolds.
    Cantore S; Crincoli V; Boccaccio A; Uva AE; Fiorentino M; Monno G; Bollero P; Derla C; Fabiano F; Ballini A; Santacroce L
    Endocr Metab Immune Disord Drug Targets; 2018; 18(5):466-469. PubMed ID: 29692270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promotion of Cell-Based Therapy: Special Focus on the Cooperation of Mesenchymal Stem Cell Therapy and Gene Therapy for Clinical Trial Studies.
    Golchin A; Rekabgardan M; Taheri RA; Nourani MR
    Adv Exp Med Biol; 2018; 1119():103-118. PubMed ID: 30155859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Trials With Mesenchymal Stem Cells: An Update.
    Squillaro T; Peluso G; Galderisi U
    Cell Transplant; 2016; 25(5):829-48. PubMed ID: 26423725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The application of resveratrol to mesenchymal stromal cell-based regenerative medicine.
    Hu C; Li L
    Stem Cell Res Ther; 2019 Oct; 10(1):307. PubMed ID: 31623691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnology for mesenchymal stem cell therapies.
    Corradetti B; Ferrari M
    J Control Release; 2016 Oct; 240():242-250. PubMed ID: 26732556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically Modified Mesenchymal Stem Cells: The Next Generation of Stem Cell-Based Therapy for TBI.
    Shahror RA; Wu CC; Chiang YH; Chen KY
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32516998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal Stromal Cell-Based Products: Challenges and Clinical Therapeutic Options.
    Mello DB; Mesquita FCP; Silva Dos Santos D; Asensi KD; Dias ML; Campos de Carvalho AC; Goldenberg RCDS; Kasai-Brunswick TH
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
    Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
    Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin plays critical role in mesenchymal stem cell-based regenerative medicine in vitro and in vivo.
    Hu C; Li L
    Stem Cell Res Ther; 2019 Jan; 10(1):13. PubMed ID: 30635065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.